HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Ju Hsieh Selected Research

cantharidic acid

3/2018Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Ju Hsieh Research Topics

Disease

83Neoplasms (Cancer)
05/2022 - 04/2003
39Mouth Neoplasms (Oral Cancer)
03/2022 - 01/2012
32Neoplasm Metastasis (Metastasis)
09/2021 - 08/2010
24Hepatocellular Carcinoma (Hepatoma)
04/2019 - 01/2012
18Nasopharyngeal Carcinoma
06/2022 - 01/2014
13Squamous Cell Carcinoma of Head and Neck
05/2022 - 10/2014
11Stroke (Strokes)
05/2022 - 05/2013
11Heart Arrest (Cardiac Arrest)
01/2022 - 11/2015
11Lung Neoplasms (Lung Cancer)
12/2021 - 02/2002
8Adenocarcinoma of Lung
12/2021 - 01/2016
8Pneumothorax
11/2021 - 11/2002
7Carcinoma (Carcinomatosis)
11/2020 - 01/2014
6Esophageal Squamous Cell Carcinoma
01/2018 - 03/2009
6Carcinogenesis
01/2018 - 03/2009
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 12/2009
5Pain (Aches)
05/2022 - 11/2015
5Liver Neoplasms (Liver Cancer)
03/2022 - 06/2014
5Out-of-Hospital Cardiac Arrest
01/2022 - 01/2018
5Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2018 - 03/2015
5Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 10/2005
5Tracheal Stenosis
12/2009 - 06/2005
4Wounds and Injuries (Trauma)
01/2022 - 11/2015
4Hemorrhage
07/2019 - 04/2003
4Osteosarcoma (Osteogenic Sarcoma)
03/2019 - 03/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2019 - 01/2016
3Burns
01/2022 - 06/2005
3Infections
01/2022 - 01/2016
3Breast Neoplasms (Breast Cancer)
03/2019 - 08/2010
3Ischemic Stroke
04/2016 - 11/2014
3Pneumonia (Pneumonitis)
07/2015 - 06/2008
3Airway Obstruction (Choking)
01/2011 - 04/2003
2Dehydration (Water Stress)
01/2022 - 12/2021
2COVID-19
01/2022 - 12/2021
2Head and Neck Neoplasms (Head and Neck Cancer)
09/2021 - 02/2019

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2010
11p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 08/2010
9Antineoplastic Agents (Antineoplastics)IBA
03/2022 - 01/2014
9ErbB Receptors (EGF Receptor)IBA
12/2021 - 01/2016
9Mitogen-Activated Protein KinasesIBA
08/2021 - 01/2012
9Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2020 - 01/2012
7CaspasesIBA
03/2022 - 01/2014
6Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2017 - 01/2012
5Messenger RNA (mRNA)IBA
05/2022 - 03/2009
5pterostilbeneIBA
01/2017 - 01/2014
4AlkaloidsIBA
03/2022 - 10/2019
4dehydrocrenatidineIBA
03/2022 - 05/2021
4Matrix Metalloproteinases (MMPs)IBA
11/2020 - 06/2016
4coronarin DIBA
08/2020 - 12/2017
4Vincristine (Oncovin)FDA LinkGeneric
03/2020 - 04/2015
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2020 - 04/2018
4Type 4 Fibroblast Growth Factor ReceptorIBA
01/2020 - 01/2015
4Peptide Hydrolases (Proteases)FDA Link
09/2019 - 01/2013
4Pharmaceutical PreparationsIBA
02/2019 - 01/2012
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2017 - 01/2012
3Oxygen (Dioxygen)IBA
05/2022 - 12/2019
3Death Domain ReceptorsIBA
03/2022 - 08/2017
3AmphiregulinIBA
01/2022 - 10/2019
3Long Noncoding RNAIBA
11/2021 - 01/2019
3Cadherins (E-Cadherin)IBA
05/2021 - 03/2016
3Tumor Biomarkers (Tumor Markers)IBA
11/2020 - 01/2014
3MelatoninIBA
03/2020 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2009
3FlavonoidsIBA
01/2020 - 08/2017
3GelatinIBA
10/2019 - 10/2017
3cathepsin SIBA
09/2019 - 01/2017
3celastrolIBA
05/2019 - 08/2017
3Coloring Agents (Dyes)IBA
03/2019 - 12/2009
3norcantharidinIBA
03/2018 - 01/2012
3hispolonIBA
01/2018 - 10/2014
3polyphyllin VIIIBA
01/2018 - 10/2016
3dioscinIBA
01/2017 - 01/2012
3dehydroandrographolideIBA
01/2017 - 10/2015
3glabridinIBA
04/2016 - 01/2014
3AntioxidantsIBA
06/2015 - 01/2014
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2015 - 01/2012
2picrasidine IIBA
05/2022 - 03/2022
2luteolin-7-glucosideIBA
10/2021 - 01/2020
2JNK Mitogen-Activated Protein KinasesIBA
09/2021 - 03/2020
2Caspase 3 (Caspase-3)IBA
05/2021 - 12/2016
2Caspase 8 (Caspase-8)IBA
05/2021 - 04/2019

Therapy/Procedure

11Resuscitation
01/2022 - 11/2002
10Cardiopulmonary Resuscitation (CPR)
01/2022 - 01/2019
9Drug Therapy (Chemotherapy)
01/2020 - 01/2014
8Therapeutics
02/2019 - 01/2012
5Length of Stay
12/2016 - 06/2008
5Chemoradiotherapy
03/2012 - 12/2009
5Stents
01/2011 - 04/2003
4Thrombectomy
05/2022 - 08/2010
4First Aid (Aids, First)
01/2022 - 12/2019
4Esophagectomy
01/2022 - 10/2005
4Thrombolytic Therapy
10/2018 - 11/2014
4Thoracotomy
01/2016 - 11/2003
3Airway Management
05/2022 - 01/2018
3Lymph Node Excision (Lymph Node Dissection)
01/2022 - 09/2012
3Punctures
11/2021 - 01/2018
3Radiotherapy
01/2020 - 01/2019
3Operative Time
06/2016 - 11/2015
2Tourniquets
01/2022 - 12/2021
2Fluid Therapy (Oral Rehydration Therapy)
01/2022 - 12/2021
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2022 - 12/2021